Effects of HQK-1001 in Patients With Sickle Cell Disease

Clinical trial NCT01601340 · TERMINATED

Trial details

NCT number: NCT01601340
Sponsor: HemaQuest Pharmaceuticals Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Sickle Cell Disease Sickle Cell Anemia Sickle Cell Disorders Hemoglobin S Disease Sickling Disorder Due to Hemoglobin S

Start date: 2012-07-01
Primary completion: 2013-11-01
Enrollment: 77

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.